Ramiro G Peru

Director Ramiro G Peru purchases 1.0K shares of ELV at $366.05, raising stake to 10.9K shares

Ramiro G Peru, a director of Elevance Health, Inc., purchased 1,000 shares at $366.05 on 2026-07-17, increasing his holdings by +10.1% to 10.9K shares. The stock currently trades at $369.40, and the company reports solid fundamentals with $50.5B revenue, $1.5B net income, and 12.5% annual revenue growth at a P/E of 16.15. However, Peru's cross-ticker track record reveals a concerning pattern: across his open-market trading history, his 1 prior buy generated an average 90-day return of -16.7% with a 0.00% win rate, suggesting this purchase aligns with his pattern of unfavorable timing. The stock itself is -15.3% from its 52-week high and down 5.6% over 30 days despite the 14.4% 90-day gain, warranting close observation of whether this transaction precedes further weakness or stabilization.

Director Ramiro G Peru buys 5,000 SM Energy shares at $28.72; 2 other insiders also bought in past 14 days amid -47.8% decline from 52-week high

Director Ramiro G Peru purchased 5,000 shares at $28.72 on 2025-03-04, increasing his holdings to 82,535 shares, while the stock trades -47.8% below its 52-week high and down -34.2% over 90 days. This transaction is part of a cluster pattern with 2 other insiders also buying within the past 14 days, suggesting coordinated interest among the board despite recent significant price depreciation. The company's fundamentals remain strong with Revenue $643.6M in the latest quarter, Net income $240.5M, annual revenue growth of +13.3%, and a low P/E of 4.03, creating a potential disconnect between operational performance and equity valuation. The cluster buy pattern in conjunction with this steep price decline and solid financial backdrop merits scrutiny of what insiders may be perceiving about near-term value or inflection points.